Upcoming Products

Our upcoming rapid test products are in various stages of development, ranging from last-mile R&D, clinical trials and obtaining regulatory approval. Currently these products can only be used for research projects only.



Human Papillomavirus (HPV)

This is a lateral flow immunochromatographic assay to detect the presence of HPV16/18 E7 antigen in cervical swab specimens.

This 15-min rapid test is intended to support medical diagnosis of cancer & precancerous conditions of the cervix.

Infection by HPV 16 & 18 can lead to cervical cancer, which is the 4th most common cancer globally.

Kratom (Mitragynine)

This is a lateral flow immunochromatographic assay to detect the presence of mitragynine in urine samples.

Mitragynine is the main active compound in kratom (ketum), a plant native to Southeast Asia. It has stimulant and opioid-like effects and is banned in several countries due to safety and abuse concerns.

Fentanyl

This is a lateral flow immunochromatographic assay to detect the presence of fentanyl abuse in urine samples.

Fentanyl is a powerful synthetic opioid introduced in the 1960s as an intravenous anesthetic. It carries a high risk of overdose, especially when misused.

Tuberculosis (TB)

This is a lateral flow immunochromatographic assay to detect the presence of TB infection in clinical samples.

Influenza A & B (Flu A/B)

This is a lateral flow immunochromatographic assay to detect the presence Flu A/B infection in respiratory samples.

Please contact us if you are interested to become our distributor partners or use for your R&D projects.

Contact us.